http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Conference on drug design and discovery technologies
Conference on Drug Design & Discovery Technologies (2019 : Karnataka, India)
This publication is based on peer-reviewed manuscripts from the 2019 Conference on Drug Design & Discovery Technologies (CDDT) held at Ramaiah University of Applied Sciences, India. Providing a wide range of up to date topics on the latest advancements in drug design and discovery technologies, this book ensures the reader receives a good understanding of the scope of the field. Aimed at scientists, students, regulators, academics and consultants throughout the world, this book is an ideal resource for anyone interested in the state of the art in drug design and discovery.
Cover -- Contents -- Part 1: Structure Based Drug Design Approach -- MOLECULAR DYNAMICS SIMULATIONS OF BACILLUS SUBTILIS EngA -- FOR EXPLORING NUCLEOTIDE DEPENDENT CONFORMATIONS -- ERRORS MADE IN AB INITIO+ HOMOLOGY-BASED PROTEIN STRUCTURE PREDICTION TOOLS ARISE DUE TO LACK OF CONSIDERATION OF IMPACT FORCES -- PARADIGM SHIFT IN RESEARCH FOCUS: COMPUTATIONAL SOFTWARES IN CANCER BIOLOGY -- VIRTUAL SCREENING OF BIO-ACTIVE COMPOUNDS AS ANINHIBITOR OF C-FLIP PROTEIN FOR CANCER TREATMENT
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF 3-PHENYLISOXAZOLO[5,4-D]PYRIMI DINE DERIVATIVES ASANTICANCER AGENTS -- QSAR AND DOCKING STUDIES ON TRIAZOLE BENZENESULFONAMIDES WITH HUMAN CARBONIC ANHYDRASE IXINHIBITORY ACTIVITY -- DESIGN AND SYNTHESIS OF SOME NOVEL ERLOTINIBDERIVATIVES AS POTENTIAL EGFR KINASE INHIBITORS -- DESIGN, SYNTHESIS AND CHARACTERIZATION OF NOVEL SERIES OF 1,3-THIAZOLE CONTAINING HETEROCYCLES AS INHIBITORS OF DHFR FOR USE AS ANTICANCER AGENTS -- IN SILICO AND IN VITRO STUDIES OF BENZOHYDRAZIDE ANALOGUES AS POTENT ANDROGEN RECEPTOR ANTAGONIST
DEVELOPMENT OF NEW NEPRILYSIN INHIBITOR AS AMODULATOR OF CHRONIC KIDNEY AND HEART DISEASE USING DRUG REPURPOSING APPROACH -- ANTICANCER POTENTIAL OF PHYTOCONSTITUENTS MODULATING NA/K ATPASE PUMP -- A NOVEL REPURPOSING STRATEGY -- IN SILICO HIT IDENTIFICATION, DRUG REPURPOSING, PHARMACOKINETIC AND TOXICITY PREDICTION OF C-MET KINASE INHIBITORS FOR CANCER THERAPY -- DESIGN POTENT TELOMERASE INHIBITORS USING STRUCTURE BASED APPROACHES
FRAGMENT-BASED DESIGN OF NOVEL INHIBITORS OF HPV16 E6 ONCOPROTEIN: MOLECULAR DOCKING, MOLECULAR DYNAMICS SIMULATION AND ADME ANALYSIS -- DESIGN AND SYNTHESIS OF NOVEL POLY ADP-RIBOSE POLYMERASE 1 (PARP1) INHIBITORS FOR THE TREATMENTOF SOLID TUMORS -- IN SILICO EVALUATION OF THE ROLE OF PHYTOCHEMICALS IN ALZHEIMER'S DISEASE THROUGH WNT SIGNALINGMODULATION -- IDENTIFICATION OF POTENTIAL VEGFR2 INHIBITORS EMPLOYING E-PHARMACOPHORE MODEL, VIRTUALSCREENING, MOLECULAR DYNAMIC SIMULATION ANDADME ANALYSIS
MOLECULAR DOCKING BASED SCREENING OF "NITROGEN CONTAINING BISPHOSPHONATE CONJUGATE WITH HYDROXYAPATITE" ACTIVE CONSTITUENTS TOWARDS MEVALONATE PATHWAY IN FINDING POTENT INHIBITORS FOR ANTI-OSTEOPOROTIC ACTIVITY -- ZANAPEZIL, A POTENTIAL REPURPOSABLE DRUG AGAINST HUNTINGTON DISEASE: AN IN SILICO FORECAST -- DRUG REPURPOSING FOR HEPATOCELLULAR CARCINOMA VIA VIRTUAL SCREENING INTEGRATED WITH BIOINFORMATICS ANALYSIS -- AN IN SILICO TARGET SPECIFIC DRUG REPURPOSING APPROACH FOR MULTIPLE SCLEROSIS -- Part 2: Structure Based Drug Design and Biological Evaluation
editors: Manikanta Murahari [and 5 more].
[Place of publication not identified] : ROYAL SOCIETY OF CHEMISTR, 2019
Special publication (Royal Society of Chemistry (Great Britain))